Boston Scientific Corporation
NYSE:BSX
Sector
Location
Market Cap
USD 152.87 B
Share Price
USD 103.17
Avg Daily Volume
7,451,374
Change (1 day)
-0.94%
Change (1 year)
32.98%
Change (YTD)
15.51%
Boston Scientific Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 16.33%
Boston Scientific Corporation EBIT Margin is 16.33% for the Trailing 12 Months (TTM) ending March 31, 2025, a -0.90% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
Boston Scientific Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 16.48%, a 27.15% change year over year.
-
Boston Scientific Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 12.96%, a 7.61% change year over year.
-
Boston Scientific Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 12.05%, a 126.63% change year over year.
-
Boston Scientific Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 5.32%, a -22.42% change year over year.
StockViz
Competitors
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Becton, Dickinson and Company
USD 195.94
BDX
+0.94
0.48%
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Sartorius Stedim Biotech S.A.
USD 207.65
DIM.PA
+1.46
0.71%
bioMérieux S.A.
USD 147.37
BIM.PA
+0.01
0.01%
United Therapeutics Corporation
USD 313.13
UTHR
+1.07
0.34%
Medpace Holdings, Inc.
USD 457.85
MEDP
-0.81
-0.18%
Revvity, Inc.
USD 90.78
RVTY
+1.33
1.49%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.61
603392.SS
+0.02
0.24%
Exact Sciences Corporation
USD 45.60
EXAS
+0.61
1.36%
Sysmex Corporation
USD 13.59
6869.T
+0.10
0.73%
Bio-Techne Corporation
USD 53.60
TECH
-0.14
-0.26%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.99
002294.SZ
+0.29
4.39%
Guardant Health, Inc.
USD 58.88
GH
-1.48
-2.45%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
Roche Holding AG
USD 331.61
RO.SW
+7.43
2.29%
Thermo Fisher Scientific Inc.
USD 489.01
TMO
+3.97
0.82%
Becton, Dickinson and Company
USD 195.94
BDX
+0.94
0.48%
Fresenius SE & Co. KGaA
USD 53.85
FRE.DE
+0.19
0.35%
Sartorius Stedim Biotech S.A.
USD 207.65
DIM.PA
+1.46
0.71%
bioMérieux S.A.
USD 147.37
BIM.PA
+0.01
0.01%
United Therapeutics Corporation
USD 313.13
UTHR
+1.07
0.34%
Medpace Holdings, Inc.
USD 457.85
MEDP
-0.81
-0.18%
Revvity, Inc.
USD 90.78
RVTY
+1.33
1.49%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.61
603392.SS
+0.02
0.24%
Exact Sciences Corporation
USD 45.60
EXAS
+0.61
1.36%
Sysmex Corporation
USD 13.59
6869.T
+0.10
0.73%
Bio-Techne Corporation
USD 53.60
TECH
-0.14
-0.26%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.99
002294.SZ
+0.29
4.39%
Guardant Health, Inc.
USD 58.88
GH
-1.48
-2.45%